Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

siRNA targeting myeloid differentiation primary response gene (88) (MYD88)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • Publication Date:
    May 6, 2010
  • معلومة اضافية
    • Document Number:
      20100113760
    • Appl. No:
      12/653120
    • Application Filed:
      December 08, 2009
    • نبذة مختصرة :
      Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for MYD88.
    • Inventors:
      Khvorova, Anastasia (Boulder, CO, US); Reynolds, Angela (Littleton, CO, US); Leake, Devin (Denver, CO, US); Marshall, William (Boulder, CO, US); Read, Steven (Denver, CO, US); Scaringe, Stephen (Lafayette, CO, US)
    • Assignees:
      DHARMACON, INC. (Lafayette, CO, US)
    • Claim:
      1. An siRNA molecule, wherein said siRNA molecule consists of: (a) a duplex region; and (b) either no overhang regions or at least one overhang region, wherein each overhang region contains six or fewer nucleotides, wherein the duplex region consists of a sense region and an antisense region, wherein said sense region and said antisense region together form said duplex region and said duplex region is 19-30 base pairs in length and said antisense region comprises a sequence that is the complement of a sequence selected from SEQ ID NOs: 438-475, 477-527 and 529-560.
    • Claim:
      2. The siRNA molecule of claim 1, wherein said antisense region and said sense region are each 19-25 bases in length.
    • Claim:
      3. The siRNA molecule of claim 2, wherein said antisense region and said sense region are each 19 bases in length.
    • Claim:
      4. The siRNA molecule of claim 1, wherein said siRNA molecule has at least one overhang region.
    • Claim:
      5. The siRNA molecule of claim 1, wherein said siRNA molecule has no overhang regions.
    • Claim:
      6. The siRNA molecule of claim 2, wherein said siRNA molecule has at least one overhang region.
    • Claim:
      7. The siRNA molecule of claim 2, wherein said siRNA molecule has no overhang regions.
    • Claim:
      8. The siRNA molecule of claim 3, wherein said siRNA molecule has at least one overhang region.
    • Claim:
      9. The siRNA molecule of claim 3, wherein said siRNA molecule has no overhang regions.
    • Claim:
      10. A chemically synthesized double stranded siRNA molecule, wherein: (a) each strand of said double stranded siRNA molecule is between 19 and 30 nucleotides in length; and (b) one strand of said siRNA molecule comprises a sequence that is the complement of a sequence selected from SEQ ID NOs: 438-475, 477-527 and 529-560.
    • Claim:
      11. The chemically synthesized double stranded siRNA molecule of-claim 20, wherein each strand of said siRNA molecule is 19 nucleotides in length.
    • Claim:
      12. A pool of at least two siRNAs, wherein said pool comprises a first siRNA and a second siRNA, wherein said first siRNA is the siRNA molecule of claim 1, wherein the duplex region of said first siRNA is a first duplex region and said second siRNA consists of a second duplex region and either no overhang regions or at least one overhang region, wherein each overhang region contains six or fewer nucleotides, wherein the second duplex region of said second siRNA comprises a sense region and an antisense region, wherein said sense region and said antisense region of said second siRNA together form said second duplex region and said second duplex region is 19-30 base pairs in length and said antisense region of said second duplex region comprises a sequence that is the complement of a sequence selected from the group consisting of a sequence selected from SEQ ID NOs: 438-475, 477-527 and 529-560.
    • Claim:
      13. The pool of claim 12, wherein said first siRNA and said second siRNA each have no overhang regions.
    • Claim:
      14. The pool of claim 12, wherein said first duplex region and said second duplex region are each 19-25 base pairs in length.
    • Claim:
      15. The pool of claim 14, wherein said first duplex region and said second duplex region are each 19 base pairs in length.
    • Claim:
      16. The pool of claim 15, wherein said first duplex region contains no overhang regions.
    • Claim:
      17. The pool of claim 15, wherein the second duplex region contains no overhang regions.
    • Claim:
      18. The pool of claim 15, wherein the first duplex region contains at least one overhang region.
    • Claim:
      19. The pool of claim 15, wherein the second duplex region contains at least one overhang region.
    • Claim:
      20. The chemically synthesized double stranded siRNA molecule of claim 10 wherein each strand of said siRNA molecule is 19-25 nucleotides in length.
    • Current U.S. Class:
      536/245
    • Current International Class:
      07
    • الرقم المعرف:
      edspap.20100113760